Otolith Labs is staying steady with a nerve-stimulating device that aims to relieve the symptoms of chronic vertigo. It has had the FDA’s ear since earning a breakthrough designation last year.

For those following the local medtech wearables scene, founder Sam Owen has some pretty good news to share.. His company, DC-based Otolith Labs, just closed a $20 million Series A led by Morningside ...

WASHINGTON, Feb. 13, 2025 /PRNewswire/ -- Otolith Labs, a medical technology company developing prescription medical devices for the treatment of vestibular disorders, announced results from an ...

WASHINGTON--(BUSINESS WIRE)--Otolith Labs, a medical technology company developing non-invasive wearable medical devices for the treatment of vestibular disorders, appointed Kevin Franck, PhD, MBA ...

WASHINGTON--(BUSINESS WIRE)--Otolith Labs, a medical technology company developing non-invasive wearable medical devices for the treatment of vestibular disorders, appointed Dan Wagner as Chief ...